Cargando…
Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
Leukemia cells are highly dependent on glucose and glutamine as bioenergetic and biosynthetic fuels. Inhibition of the metabolism of glucose but also of glutamine is thus proposed as a therapeutic modality to block leukemia cell growth. Since glucose also supports protein glycosylation, we wondered...
Autores principales: | Polet, Florence, Martherus, Ruben, Corbet, Cyril, Pinto, Adan, Feron, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216804/ https://www.ncbi.nlm.nih.gov/pubmed/27344174 http://dx.doi.org/10.18632/oncotarget.10131 |
Ejemplares similares
-
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth
por: Polet, Florence, et al.
Publicado: (2015) -
Discovery of Mitochondrial Complex I Inhibitors as Anticancer and Radiosensitizer Drugs Based on Compensatory Stimulation of Lactate Release
por: Lan, Junjie, et al.
Publicado: (2022) -
Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018) -
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018) -
Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach
por: Rajasinghe, Lichchavi Dhananjaya, et al.
Publicado: (2019)